Cortex Pharmaceuticals Inc.: The Irvine-based company said...

Cortex Pharmaceuticals Inc.: The Irvine-based company said Friday that its shareholders approved a 1-for-5 reverse stock split at the company’s annual meeting Thursday. The split will become effective Jan. 11. “We hope a higher per share price will attract more institutional investors,” said Scott Hagen, Cortex’s chief financial officer.